Please provide your email address to receive an email when new articles are posted on . Evaluating pulmonary artery flow and cardiac function with MRI revealed parameters that detect bronchopulmonary ...
Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, ...
(HealthDay News) — Magnetic resonance imaging (MRI) measures can predict outcomes in pulmonary arterial hypertension (PAH), according to a study published online in the American Journal of Respiratory ...
Avalyn Pharma Inc., (“Avalyn” or the “Company”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory ...
Reston, VA—A newly developed PET imaging agent, 64 Cu-GPVI-Fc, can non-invasively identify pulmonary fibrosis in its early stages, reducing the need for unnecessary biopsies and allowing patients to ...
• Quantitative parameters K trans and V e values of contrast enhanced magnetic resonance imaging (DCE-MRI) showed high diagnostic efficacy for malignant solid solitary pulmonary nodules (SSPNs). • ...
In patients with long COVID, lower pulmonary gas exchange may be associated with impaired cognitive function, according to a study being presented next week at the annual meeting of the Radiological ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results